EPM speaks to Neil Tween, CFO at Owlstone Medical, who tells us why diagnostics still have a vital role to play in healthcare and the lessons he's learned from working in the industry.
Meet the maker
Could you give us a brief description of yourself and what you do at Owlstone Medical?
I am a chartered accountant by trade, having trained with Deloitte within their audit practice. After six years with Deloitte, I moved into industry to be Financial Controller at a technology company before joining GW Pharmaceuticals plc just after their listing on the NASDAQ market in 2013. During my time there, we grew from a 180-person R&D company into a fully commercial organisation spanning multiple countries.
At Owlstone Medical, I am the Chief Financial Officer. I have only been in the position since the end of March so I am still learning the ropes, but my group is responsible for the delivery of all elements of internal and external financial reporting and operations, as Owlstone Medical looks to scale up in our search for breath biomarkers. I also help steer matters from a board and leadership team agenda.